ARCHIVES

St. John’s Wort Not Indicated For Patients On Irinotecan

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

Two New Organ Systems Working Groups to Be Considered By NCAB

October 4, 1985

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

Breast Cancer Coalition Demonstrations Crucial To Obtaining Windfall

October 16, 1992

October issue of Business & Regulatory Report (8-page issue).

November 2, 2002

Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL

April 28, 1995

Cancer Program Depend On Vitality Of Centers, Broder ells DCPC Board

May 12, 1989